Pim-Bart Feijens spec. staff member - expert

Publications Pim-Bart Feijens

In vivo bioluminescence imaging reveals differences in Leishmania infantum parasite killing kinetics by antileishmanial reference drugs

Source
ACS Infectious Diseases - ISSN 2373-8227-10:6 (2024) p. 2101-2107
Author(s)

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc₁

Source
Science translational medicine - ISSN 1946-6234-15:726 (2023) p.
Author(s)
    Stéphanie Braillard, Martine Keenan, Karen J. Breese, Jacob Heppell, Michael Abbott, Rafiqul Islam, David M. Shackleford, Kasiram Katneni, Elly Crighton, Gong Chen, Rahul Patil, Given Lee, Karen L. White, Sandra Carvalho, Richard J. Wall, Giulia Chemi, Fabio Zuccotto, Silvia González, Maria Marco, Julianna Deakyne, David Standing, Gino Brunori, Jonathan J. Lyon, Pablo Castañeda-Casado, Isabel Camino, Maria S. Martinez Martinez, Bilal Zulfiqar, Vicky M. Avery, Pim-Bart Feijens, Natascha Van Pelt, An Matheeussen, Sarah Hendrickx, Louis Maes, Guy Caljon, Vanessa Yardley, Susan Wyllie, Susan A. Charman, Eric Chatelain

Exploration of 6-methyl-7-(Hetero)Aryl-7-Deazapurine ribonucleosides as antileishmanial agents

Source
European journal of medicinal chemistry - ISSN 0223-5234-237 (2022) p. 1-17
Author(s)